Literature DB >> 12723757

Choto-san prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats.

Yutaka Shimada1, Qiao Yang, Koichi Yokoyama, Hirozo Goto, Yuji Kasahara, Nobuyasu Sekiya, Hiroaki Hikiami, Katsutoshi Terasawa.   

Abstract

The effects of long-term oral administration of choto-san (diao-teng-san in Chinese) extract on the occurrence of stroke and life span were investigated in stroke-prone spontaneously hypertensive rats (SHR-SPs). Twenty-four rats were ramdomized into three groups. From 8 weeks of age, 0.1% and 0.3% choto-san groups were given water containing 0.1% (150 mg/kg/day) and 0.3% (450 mg/kg/day) choto-san extract, respectively. A control group was given only water. The mean survival times of the control group, 0.1% and 0.3% choto-san groups were 122.1, 159.8 and 176.8 days, respectively. The percent survivals of both the 0.1% and 0.3% choto-san groups were significantly enhanced compared to the control (Kaplan-Meier analysis followed by log-rank test; 0.1% choto-san: p < 0.05; 0.3% choto-san: p < 0.05). Furthermore, the cumulative percent occurrence of neurological and behavioral signs accompying stroke in the 0.3% choto-san group was significantly inhibited compared to the control (p < 0.05). These results suggested that choto-san prevents the occurrence of stroke and prolongs the life span of SHR-SPs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723757     DOI: 10.1142/S0192415X03000837

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  Endothelium-independent vasodilator effect of isocorynoxeine in vitro isolated from the hook of Uncaria rhynchophylla (Miquel).

Authors:  Ting Li; Ke Xu; Delu Che; Zhuangzhuang Huang; Nabila Jahan; Sicen Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-02       Impact factor: 3.000

Review 2.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

3.  Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice.

Authors:  Hyung Bum Seo; Bo Kyung Kang; Ji Hyun Kim; Young Whan Choi; Jin Woo Hong; Byung Tae Choi; Hwa Kyoung Shin
Journal:  BMC Complement Altern Med       Date:  2015-05-27       Impact factor: 3.659

4.  Quantitative Analysis and Biological Efficacies regarding the Neuroprotective and Antineuroinflammatory Actions of the Herbal Formula Jodeungsan in HT22 Hippocampal Cells and BV-2 Microglia.

Authors:  Yu Jin Kim; Hye-Sun Lim; Bu-Yeo Kim; Chang-Seob Seo; Soo-Jin Jeong
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-17       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.